Encompass Health Corp (EHC) Receives Average Rating of “Hold” from Analysts

Shares of Encompass Health Corp (AMEX:EHC) have been given an average recommendation of “Hold” by the fourteen ratings firms that are covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation, five have given a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $58.22.

Several research firms recently issued reports on EHC. Zacks Investment Research raised shares of Encompass Health from a “hold” rating to a “buy” rating and set a $60.00 price objective for the company in a report on Tuesday, January 30th. Credit Suisse Group began coverage on shares of Encompass Health in a report on Wednesday, January 17th. They set an “outperform” rating and a $58.00 price objective for the company. Royal Bank of Canada upped their price objective on shares of Encompass Health to $64.00 and gave the stock an “outperform” rating in a report on Thursday, March 1st. Stephens reaffirmed a “buy” rating and set a $55.00 price objective on shares of Encompass Health in a report on Friday, January 12th. Finally, Wells Fargo began coverage on shares of Encompass Health in a report on Tuesday, January 30th. They set a “market perform” rating and a $56.00 price objective for the company.

How to Become a New Pot Stock Millionaire

A number of institutional investors have recently modified their holdings of the business. Barrow Hanley Mewhinney & Strauss LLC bought a new stake in Encompass Health in the 4th quarter valued at $65,366,000. Eagle Asset Management Inc. acquired a new position in shares of Encompass Health in the 4th quarter valued at $53,001,000. Carillon Tower Advisers Inc. acquired a new position in shares of Encompass Health in the 4th quarter valued at $37,984,000. Copeland Capital Management LLC acquired a new position in shares of Encompass Health in the 4th quarter valued at $28,117,000. Finally, Dalton Greiner Hartman Maher & Co. acquired a new position in shares of Encompass Health in the 4th quarter valued at $16,395,000. 93.18% of the stock is owned by hedge funds and other institutional investors.

Shares of Encompass Health (AMEX:EHC) traded down $0.42 during midday trading on Friday, reaching $57.67. 620,391 shares of the company were exchanged, compared to its average volume of 618,344. The company has a debt-to-equity ratio of 1.89, a quick ratio of 1.34 and a current ratio of 1.34. The firm has a market capitalization of $5,670.00, a price-to-earnings ratio of 21.28, a P/E/G ratio of 1.70 and a beta of 0.48. Encompass Health has a 1 year low of $40.86 and a 1 year high of $59.29.

Encompass Health (AMEX:EHC) last posted its quarterly earnings data on Monday, February 26th. The company reported $0.70 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.64 by $0.06. The business had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1 billion. Encompass Health had a net margin of 8.67% and a return on equity of 23.56%. Encompass Health’s quarterly revenue was up 7.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.72 EPS. analysts anticipate that Encompass Health will post 2.72 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Monday, April 16th. Shareholders of record on Monday, April 2nd will be issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 1.73%. The ex-dividend date is Thursday, March 29th. Encompass Health’s dividend payout ratio (DPR) is presently 36.90%.

WARNING: This piece was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another domain, it was stolen and republished in violation of US & international trademark and copyright law. The legal version of this piece can be read at https://www.dispatchtribunal.com/2018/04/08/encompass-health-corp-ehc-receives-average-rating-of-hold-from-analysts.html.

About Encompass Health

Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.

Analyst Recommendations for Encompass Health (AMEX:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply